ClinConnect ClinConnect Logo
Search / Trial NCT04328584

Intraoperative Navigation for Surgically Precise Resection of the Chest (INSPIRE)

Launched by UNIVERSITY HEALTH NETWORK, TORONTO · Mar 30, 2020

Trial Information

Current as of July 04, 2025

Recruiting

Keywords

ClinConnect Summary

The INSPIRE trial is studying a new way to help surgeons remove chest wall lesions more accurately during surgery. This is important because making sure the surgeon removes enough tissue around the lesion, known as the surgical margin, can help prevent complications like needing more surgery or complex repairs afterward. The trial uses advanced technology that combines patient images with real-time information during the operation, aiming to improve the precision of the surgery.

To participate in the trial, you need to be at least 18 years old, able to provide informed consent (which means you understand the study and agree to take part), and scheduled for surgery to remove a chest wall lesion. However, if you have certain medical conditions, like unresectable lesions or specific metal implants that could interfere with the technology, you may not be eligible. If you join the trial, you can expect to receive careful monitoring and support throughout the process, and you'll be contributing to important research that could improve surgical outcomes for future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Ability to provide informed consent
  • 2. Scheduled to undergo surgical resection of a chest wall lesion
  • 3. At least 18 years of age
  • 4. Must sign and be given a copy of the written informed consent form
  • Exclusion Criteria:
  • 1. Unresectable lesions or unstable patient condition, for which surgery is not recommended
  • 2. Participants with metallic implantation, such as ribs fixations, a pacemaker, or pedicle screws, which may affect the accuracy of CBCT
  • 3. Excluded at the discretion of the clinical investigator/surgeon, if they are enrolled in other studies that will result in combined radiation exposure exceeding standard of care
  • 4. Pregnant, lactating, or planning to become pregnant during the period of the evaluation

About University Health Network, Toronto

University Health Network (UHN), based in Toronto, is a leading academic health sciences center dedicated to advancing patient care through innovative research and education. As a prominent sponsor of clinical trials, UHN integrates cutting-edge scientific discoveries with clinical practice, facilitating the development of new therapies and treatment modalities. With a commitment to improving health outcomes, UHN collaborates with a diverse network of researchers, healthcare professionals, and industry partners, fostering an environment that prioritizes patient safety and ethical standards in clinical research. Through its extensive resources and expertise, UHN plays a pivotal role in transforming healthcare and enhancing the quality of life for patients both locally and globally.

Locations

Toronto, Ontario, Canada

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials